Status:
COMPLETED
European Carto® XP REgistry for Validating Specialized CFAE SOftware
Lead Sponsor:
Biosense Webster EMEA
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
The purpose of this prospective observational study (registry) is to determine the acute success rate of a complex fractionated atrial electrogram (CFAE) guided ablation procedure using a dedicated so...
Detailed Description
This was a prospective, multi-center, observational registry study evaluating CARTO® XP CFAE Software (CFAE Software) in subjects with chronic AF requiring CFAE-guided RFCA. Use of the CARTO® 3 System...
Eligibility Criteria
Inclusion
- Persistent or longstanding persistent AF
Exclusion
- Previously underwent RF ablation for AF and patients with paroxysmal AF
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT00812916
Start Date
September 1 2008
End Date
December 1 2010
Last Update
February 8 2016
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Henri Mondor
Créteil, France
2
Hôpital Saint Joseph
Marseille, France, 13001
3
Hôpital Privé Jacques Cartier Service de Rhytmologie
Massy, France
4
CHU Arnaud de Villeneuve
Montpellier, France, 34295